{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T18:33:13Z","timestamp":1775500393806,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41433-019-0620-y","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T08:02:51Z","timestamp":1570089771000},"page":"607-608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["ROP in Asia"],"prefix":"10.1038","volume":"34","author":[{"given":"G. G. W.","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"620_CR1","doi-asserted-by":"crossref","unstructured":"Sen P, Wu WC, Chandra P, Vinekar A, Manchegowda PT, Bhende P. Retinopathy of prematurity treatment: Asian perspectives. Eye (Lond). 2019. In Press.","DOI":"10.1038\/s41433-019-0643-4"},{"key":"620_CR2","unstructured":"Project operational guidelines. Prevention of Blindness from Retinopathy of Prematurity in Neonatal Care Units. \nhttps:\/\/phfi.org\/wp-content\/uploads\/2019\/05\/2018-ROP-operational-guidelines.pdf."},{"key":"620_CR3","doi-asserted-by":"publisher","unstructured":"Adams GGW, Bunce C, Xing W, Butler L, Long V, Reddy A, et al. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk. BMJ Open. 2017;7. \nhttps:\/\/doi.org\/10.1136\/bmjopen-2016-013366\n\n.","DOI":"10.1136\/bmjopen-2016-013366"},{"key":"620_CR4","doi-asserted-by":"publisher","unstructured":"Askie LM, Darlow BA, Davis PG, Finer N, Stenson B, Vento M, et al. Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants. Cochrane Database Syst Rev. 2017;2017. \nhttps:\/\/doi.org\/10.1002\/14651858.CD011190.pub2\n\n.","DOI":"10.1002\/14651858.CD011190.pub2"},{"key":"620_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.4103\/ijo.IJO_561_18","volume":"67","author":"DP Gopal","year":"2019","unstructured":"Gopal DP, Rani PK, Rao HL, Jalali S. Prospective study of factors influencing timely versus delayed presentation of preterm babies for retinopathy of prematurity screening at a tertiary eye hospital in India. The Indian Twin Cities ROP Screening (ITCROPS). Indian J Ophthalmol. 2019;67:855\u20139.","journal-title":"Indian J Ophthalmol."},{"key":"620_CR6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4103\/ijo.IJO","volume":"67","author":"TR Padhi","year":"2019","unstructured":"Padhi TR, Badhani A, Mahajan S, Savla LP, Sutar S, Jalali S, et al. Barriers to timely presentation for appropriate care of retinopathy of prematurity in Odisha, Eastern India. Indian J Ophthalmol. 2019;67:824\u20137. \nhttps:\/\/doi.org\/10.4103\/ijo.IJO\n\n.","journal-title":"Indian J Ophthalmol."},{"key":"620_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/bjophthalmol-2017-310709","volume":"102","author":"JS Mora","year":"2018","unstructured":"Mora JS, Waite C, Gilbert CE, Breidenstein B, Sloper JJ. A worldwide survey of retinopathy of prematurity screening. Br J Ophthalmol. 2018;102:9\u201313. \nhttps:\/\/doi.org\/10.1136\/bjophthalmol-2017-310709\n\n.","journal-title":"Br J Ophthalmol."},{"key":"620_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4103\/ijo.IJO","volume":"67","author":"A Vinekar","year":"2019","unstructured":"Vinekar AR. The Indian Retinopathy of Prematurity (iROP) society: challenges ahead. Indian J Ophthalmol. 2019;67:722 \nhttps:\/\/doi.org\/10.4103\/ijo.IJO","journal-title":"Indian J Ophthalmol"},{"key":"620_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tjo.2014.04.001","volume":"4","author":"SJ Lin","year":"2014","unstructured":"Lin SJ, Yang CM, Yeh PT, Ho TC. Smartphone fundoscopy for retinopathy of prematurity. Taiwan J Ophthalmol. 2014;4:82\u201385. \nhttps:\/\/doi.org\/10.1016\/j.tjo.2014.04.001\n\n.","journal-title":"Taiwan J Ophthalmol."},{"key":"620_CR10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.4103\/ijo.IJO","volume":"67","author":"T Lekha","year":"2019","unstructured":"Lekha T, Ramesh S, Sharma AAG. MII RetCam assisted smartphone based fundus imaging for retinopathy of prematurity. Indian J Ophthalmol. 2019;67:834\u20139. \nhttps:\/\/doi.org\/10.4103\/ijo.IJO\n\n.","journal-title":"Indian J Ophthalmol."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0620-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:08:38Z","timestamp":1684616918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0620-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,3]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0620-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,3]]},"assertion":[{"value":"10 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Funding from Bayer to support an ROP research project. I am Chair of the RCOphth ROP treatment guidelines committee. I am Co-chair of the RCPCH ROP screening guidelines committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}